Besides this, fucoidan therapy also suppresses NF-kB and activator protein-1 (AP-1) transcription factors that are deregulated in cancer, inhibiting tumorigenesis, promotion, and metastasis [90,91]. The gene discussed is FOS; the disease is cancer.